We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
PABPC1 is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average pTPM
1045.7
Number of samples
349
Samples
Sample
Description
pTPM
TCGA-24-1464-01A
70 years, female, white, stage:Stage IIIC, dead, 379 days
3435.8
TCGA-59-2348-01A
59 years, female, white, stage:Stage IIIC, alive, 5481 days
2967.8
TCGA-VG-A8LO-01A
55 years, female, black or african american, stage:Stage IV, dead, 24 days
2911.4
TCGA-36-1568-01A
52 years, female, stage:Stage IIIC, alive, 875 days
2768.1
TCGA-25-2393-01A
81 years, female, white, stage:Stage IIIC, dead, 1157 days
2707.0
TCGA-57-1584-01A
47 years, female, white, stage:Stage IIIC, alive, 643 days
2610.9
TCGA-24-1435-01A
57 years, female, white, stage:Stage IIIC, dead, 1324 days
2496.6
TCGA-30-1857-01A
64 years, female, white, stage:Stage IV, dead, 8 days
2429.0
TCGA-24-1553-01A
53 years, female, white, stage:Stage IIIB, dead, 1767 days
2273.3
TCGA-29-1705-01A
47 years, female, white, stage:Stage IIIC, dead, 555 days
2265.4
TCGA-31-1946-01A
30 years, female, stage:Stage IIIC, alive, 918 days
2213.7
TCGA-36-1570-01A
49 years, female, white, stage:Stage IIIC, alive, 655 days
2188.1
TCGA-36-1569-01A
52 years, female, white, stage:Stage IIIC, alive, 885 days
2177.1
TCGA-24-2033-01A
87 years, female, white, stage:Stage IIIC, dead, 562 days
2133.3
TCGA-24-0979-01A
53 years, female, white, stage:Stage IV, dead, 1264 days
2081.2
TCGA-59-A5PD-01A
55 years, female, black or african american, stage:Stage IC, dead, 624 days
2080.0
TCGA-09-1662-01A
58 years, female, white, stage:Stage IV, dead, 2717 days
2061.6
TCGA-30-1853-01A
58 years, female, white, stage:Stage IIIC, dead, 1103 days
2031.9
TCGA-24-1846-01A
45 years, female, stage:Stage IIIC, alive, 133 days
2010.7
TCGA-61-1725-01A
40 years, female, white, stage:Stage IIIC, alive, 956 days
1988.1
TCGA-36-1571-01A
53 years, female, white, stage:Stage IIIB, dead, 695 days
1980.6
TCGA-25-1318-01A
54 years, female, white, stage:Stage IIIC, dead, 1064 days
1973.2
TCGA-61-2008-01A
40 years, female, asian, stage:Stage IIC, alive, 932 days
1959.5
TCGA-24-1419-01A
62 years, female, white, stage:Stage IIIC, alive, 239 days
1899.8
TCGA-31-1944-01A
47 years, female, white, stage:Stage IIIC, alive, 1386 days
1896.5
TCGA-29-1776-01A
63 years, female, black or african american, stage:Stage IIIC, alive, 360 days
1896.3
TCGA-04-1542-01A
52 years, female, white, stage:Stage IIIB, dead, 2561 days
1896.2
TCGA-24-2023-01A
54 years, female, white, stage:Stage IIIA, dead, 1364 days
1846.8
TCGA-61-2097-01A
71 years, female, white, stage:Stage IIC, alive, 1844 days
1841.1
TCGA-5X-AA5U-01A
61 years, female, black or african american, stage:Stage IIC, alive, 361 days
1837.7
TCGA-59-2355-01A
58 years, female, white, stage:Stage IV, dead, 65 days
1835.4
TCGA-04-1361-01A
57 years, female, white, stage:Stage IIIB, alive, 989 days
1833.8
TCGA-13-0720-01A
48 years, female, white, stage:Stage IIIC, dead, 1355 days
1827.0
TCGA-25-1329-01A
76 years, female, white, stage:Stage IIIC, dead, 457 days
1811.8
TCGA-24-1425-01A
45 years, female, white, stage:Stage IIIC, alive, 181 days
1809.7
TCGA-61-1724-01A
47 years, female, white, stage:Stage IIIC, dead, 637 days
1801.4
TCGA-23-2084-01A
45 years, female, white, stage:Stage IV, dead, 1516 days
1769.1
TCGA-04-1364-01A
61 years, female, white, stage:Stage IIIC, dead, 1024 days
1750.6
TCGA-24-1417-01A
54 years, female, white, stage:Stage IV, alive, 238 days
1748.9
TCGA-23-2078-01A
66 years, female, white, stage:Stage IIIC, alive, 2661 days
1730.3
TCGA-24-1467-01A
51 years, female, white, stage:Stage IIIC, dead, 3224 days
1713.4
TCGA-24-1842-01A
49 years, female, white, stage:Stage IIIC, alive, 253 days
1709.8
TCGA-23-1116-01A
83 years, female, white, stage:Stage IIIC, dead, 592 days
1709.4
TCGA-24-1567-01A
54 years, female, white, stage:Stage IIIB, dead, 524 days
1707.4
TCGA-61-2109-01A
40 years, female, white, stage:Stage IIIC, dead, 629 days
1701.6
TCGA-24-1427-01A
58 years, female, stage:Stage IIIC, alive, 147 days
1684.3
TCGA-09-1670-01A
57 years, female, white, stage:Stage IIIA, alive, 547 days
1678.5
TCGA-13-1501-01A
50 years, female, white, stage:Stage IV, dead, 1314 days
1673.7
TCGA-25-1322-01A
62 years, female, white, stage:Stage IV, dead, 91 days
1666.9
TCGA-57-1582-01A
50 years, female, white, stage:Stage IIIC, dead, 731 days
1650.6
TCGA-61-1907-01A
63 years, female, white, stage:Stage IIIC, alive, 952 days
1630.9
TCGA-24-1552-01A
77 years, female, white, stage:Stage IIIC, dead, 1259 days
1589.8
TCGA-13-0724-01A
72 years, female, white, stage:Stage IV, dead, 83 days
1569.3
TCGA-25-1326-01A
61 years, female, white, stage:Stage IIIC, dead, 1249 days
1566.5
TCGA-09-1673-01A
50 years, female, white, stage:Stage IV, alive, 92 days
1551.0
TCGA-29-A5NZ-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
1509.6
TCGA-13-1512-01A
49 years, female, white, stage:Stage IIIC, alive, 442 days
1509.3
TCGA-25-2042-01A
60 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
1506.1
TCGA-25-2404-01A
38 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
1501.9
TCGA-24-1105-01A
36 years, female, white, stage:Stage IIIC, dead, 1442 days
1486.7
TCGA-25-2399-01A
80 years, female, white, stage:Stage IIIC, dead, 608 days
1482.8
TCGA-61-2002-01A
46 years, female, white, stage:Stage IIIC, alive, 547 days
1473.8
TCGA-25-1316-01A
55 years, female, white, stage:Stage IIIC, dead, 1279 days
1470.3
TCGA-24-1923-01A
51 years, female, white, stage:Stage IIIC, dead, 690 days
1468.2
TCGA-13-1483-01A
61 years, female, white, stage:Stage IIIC, dead, 895 days
1457.4
TCGA-25-1635-01A
71 years, female, white, stage:Stage IIIC, dead, 1583 days
1455.2
TCGA-29-1694-01A
45 years, female, white, stage:Stage IIIC, dead, 1187 days
1451.0
TCGA-04-1338-01A
78 years, female, white, stage:Stage IIIC, alive, 1418 days
1440.7
TCGA-24-2271-01A
55 years, female, asian, stage:Stage IIIC, dead, 962 days
1424.6
TCGA-24-2297-01A
56 years, female, white, stage:Stage IIIC, dead, 1699 days
1419.1
TCGA-24-1563-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
1408.1
TCGA-23-1119-01A
64 years, female, white, stage:Stage IIIC, alive, 3953 days
1406.8
TCGA-20-1687-01A
46 years, female, white, stage:Stage IV, alive, 81 days
1404.6
TCGA-57-1586-01A
66 years, female, white, stage:Stage IIIC, alive, 679 days
1393.6
TCGA-04-1362-01A
59 years, female, white, stage:Stage IIC, dead, 1348 days
1393.2
TCGA-10-0938-01A
80 years, female, white, stage:Stage IIIC, dead, 636 days
1391.6
TCGA-59-2363-01A
40 years, female, asian, stage:Stage IIIA, alive, 165 days
1374.8
TCGA-WR-A838-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 304 days
1370.1
TCGA-24-2290-01A
56 years, female, white, stage:Stage IIIC, dead, 1102 days
1367.2
TCGA-30-1861-01A
74 years, female, white, stage:Stage IIIC, dead, 1058 days
1361.9
TCGA-25-1320-01A
65 years, female, white, stage:Stage IIIC, dead, 1155 days
1361.2
TCGA-24-1562-01A
67 years, female, white, stage:Stage IIIC, dead, 1384 days
1357.8
TCGA-61-1918-01A
45 years, female, white, stage:Stage IV, dead, 479 days
1349.5
TCGA-36-1574-01A
48 years, female, asian, stage:Stage IIIC, alive, 686 days
1338.4
TCGA-25-2401-01A
64 years, female, white, stage:Stage IIIC, dead, 90 days
1337.4
TCGA-25-1631-01A
73 years, female, white, stage:Stage IIIC, dead, 9 days
1337.0
TCGA-29-1701-01A
56 years, female, white, stage:Stage IIIC, dead, 515 days
1329.6
TCGA-24-1546-01A
46 years, female, white, stage:Stage IIIC, dead, 1955 days
1311.4
TCGA-23-1022-01A
67 years, female, white, stage:Stage IIIC, dead, 1511 days
1279.9
TCGA-OY-A56Q-01A
78 years, female, black or african american, stage:Stage IIA, alive, 576 days
1279.0
TCGA-29-1703-01A
56 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
1273.3
TCGA-61-1995-01A
43 years, female, white, stage:Stage IIIC, alive, 61 days
1263.7
TCGA-61-1919-01A
58 years, female, white, stage:Stage IIIC, dead, 1161 days
1263.1
TCGA-10-0937-01A
44 years, female, white, stage:Stage IIIC, dead, 608 days
1261.0
TCGA-25-1633-01A
64 years, female, white, stage:Stage IIIC, dead, 1891 days
1260.5
TCGA-24-0982-01A
77 years, female, white, stage:Stage IIIC, dead, 679 days
1260.4
TCGA-24-2261-01A
76 years, female, white, stage:Stage IIIC, dead, 24 days
1254.5
TCGA-29-1783-01A
58 years, female, white, stage:Stage IIIC, alive, 220 days
1251.3
TCGA-25-1328-01A
38 years, female, white, stage:Stage IIIC, dead, 2009 days
1247.9
TCGA-24-1844-01A
64 years, female, white, stage:Stage IIIC, alive, 113 days
1230.2
TCGA-24-1565-01A
74 years, female, white, stage:Stage IIIC, dead, 312 days
1229.8
TCGA-09-0364-01A
80 years, female, white, stage:Stage IIC, dead, 887 days
1209.9
TCGA-24-2281-01A
68 years, female, white, stage:Stage IIA, alive, 1357 days
1209.2
TCGA-24-1604-01A
66 years, female, white, stage:Stage IIIC, dead, 2688 days
1203.7
TCGA-61-2000-01A
67 years, female, white, stage:Stage IIIC, alive, 441 days
1203.4
TCGA-24-1474-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 676 days
1202.5
TCGA-61-1728-01A
59 years, female, white, stage:Stage IV, alive, 848 days
1198.1
TCGA-13-1409-01A
73 years, female, white, stage:Stage IIIC, dead, 1742 days
1195.5
TCGA-13-1485-01A
48 years, female, white, stage:Stage IV, dead, 629 days
1185.6
TCGA-13-0885-01A
70 years, female, white, stage:Stage IIIC, alive, 3388 days
1185.6
TCGA-04-1356-01A
62 years, female, white, stage:Stage IIC, dead, 1499 days
1178.2
TCGA-25-2392-01A
75 years, female, white, stage:Stage IV, dead, 31 days
1177.6
TCGA-20-1686-01A
75 years, female, white, stage:Stage IIIC, alive, 89 days
1175.0
TCGA-25-1623-01A
71 years, female, white, stage:Stage IV, dead, 565 days
1174.0
TCGA-29-1778-01A
77 years, female, white, stage:Stage IIIC, alive, 454 days
1172.4
TCGA-13-2060-01A
51 years, female, white, stage:Stage IV, alive, 2369 days
1169.4
TCGA-24-1847-01A
45 years, female, white, stage:Stage IV, alive, 343 days
1167.5
TCGA-13-A5FT-01A
67 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
1161.9
TCGA-25-1632-01A
68 years, female, white, stage:Stage IV, dead, 1799 days
1159.8
TCGA-24-1103-01A
50 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
1155.4
TCGA-24-1471-01A
60 years, female, white, stage:Stage IIIC, alive, 36 days
1153.8
TCGA-13-1404-01A
48 years, female, white, stage:Stage IIIC, alive, 2469 days
1148.6
TCGA-24-1550-01A
49 years, female, white, stage:Stage IIIC, dead, 1249 days
1148.6
TCGA-59-2354-01A
63 years, female, white, stage:Stage IIIC, dead, 1046 days
1147.2
TCGA-13-0883-01A
61 years, female, white, stage:Stage IIIC, dead, 2097 days
1144.4
TCGA-13-0726-01A
55 years, female, white, stage:Stage IIIC, dead, 949 days
1143.5
TCGA-61-1910-01A
56 years, female, white, stage:Stage IIC, alive, 1127 days
1138.1
TCGA-13-0714-01A
55 years, female, white, stage:Stage IV, dead, 189 days
1135.8
TCGA-13-1403-01A
48 years, female, white, stage:Stage IIIC, dead, 2345 days
1127.5
TCGA-24-2035-01A
65 years, female, white, stage:Stage IIIC, dead, 857 days
1125.6
TCGA-04-1651-01A
53 years, female, white, stage:Stage IIIC, dead, 1102 days
1120.4
TCGA-23-1111-01A
63 years, female, white, stage:Stage IIIC, alive, 98 days
1118.7
TCGA-24-1434-01A
59 years, female, white, stage:Stage IIIC, dead, 568 days
1113.6
TCGA-23-1024-01A
52 years, female, white, stage:Stage IV, alive, 468 days
1113.6
TCGA-25-1323-01A
72 years, female, white, stage:Stage IIIC, dead, 395 days
1110.7
TCGA-30-1892-01A
52 years, female, white, stage:Stage IIIC, dead, 1484 days
1108.0
TCGA-13-0886-01A
67 years, female, white, stage:Stage IIIC, alive, 4665 days
1103.3
TCGA-29-1768-01A
50 years, female, white, stage:Stage IV, dead, 952 days
1101.2
TCGA-24-1430-01A
68 years, female, white, stage:Stage IIIC, dead, 863 days
1100.4
TCGA-09-2051-01A
42 years, female, white, stage:Stage IIIC, alive, 1919 days
1098.7
TCGA-24-1422-01A
82 years, female, black or african american, stage:Stage IIIC, dead, 23 days
1096.1
TCGA-61-2111-01A
61 years, female, white, stage:Stage IV, alive, 3825 days
1091.6
TCGA-29-1695-01A
62 years, female, white, stage:Stage IIIC, dead, 1229 days
1089.2
TCGA-61-1737-01A
42 years, female, white, stage:Stage IV, alive, 1364 days
1085.4
TCGA-24-2289-01A
68 years, female, white, stage:Stage IV, dead, 2049 days
1084.9
TCGA-24-1551-01A
53 years, female, white, stage:Stage IIIC, dead, 1579 days
1082.3
TCGA-29-1690-01A
66 years, female, white, stage:Stage IIIC, dead, 1448 days
1079.5
TCGA-24-1603-01A
53 years, female, white, stage:Stage IIIB, dead, 2742 days
1079.1
TCGA-25-1627-01A
73 years, female, white, stage:Stage IIIC, dead, 394 days
1074.5
TCGA-31-1951-01A
58 years, female, white, stage:Stage IIIC, alive, 684 days
1073.1
TCGA-24-1416-01A
34 years, female, white, stage:Stage IV, alive, 194 days
1071.6
TCGA-24-2038-01A
68 years, female, white, stage:Stage IIIA, dead, 1354 days
1070.4
TCGA-23-1118-01A
45 years, female, white, stage:Stage IIIC, alive, 2616 days
1067.9
TCGA-61-2113-01A
53 years, female, white, stage:Stage IIC, dead, 676 days
1065.7
TCGA-24-1616-01A
56 years, female, white, stage:Stage IIIC, dead, 1163 days
1063.6
TCGA-13-1408-01A
59 years, female, white, stage:Stage IIIC, dead, 1680 days
1063.6
TCGA-29-2414-01A
75 years, female, white, stage:Stage IIIC, dead, 2621 days
1058.6
TCGA-13-1505-01A
63 years, female, white, stage:Stage IIIC, alive, 1998 days
1054.8
TCGA-24-2298-01A
55 years, female, white, stage:Stage IIIC, dead, 1620 days
1053.4
TCGA-24-2027-01A
51 years, female, white, stage:Stage IV, dead, 3337 days
1048.3
TCGA-24-1413-01A
51 years, female, white, stage:Stage IIIC, alive, 192 days
1047.8
TCGA-13-1487-01A
74 years, female, white, stage:Stage IV, dead, 681 days
1039.9
TCGA-61-1998-01A
48 years, female, white, stage:Stage IIIC, alive, 168 days
1037.9
TCGA-10-0927-01A
65 years, female, stage:Stage IIIC, dead, 2490 days
1028.0
TCGA-25-1317-01A
66 years, female, white, stage:Stage IIIC, dead, 61 days
1021.6
TCGA-61-2092-01A
57 years, female, white, stage:Stage IIIC, alive, 1573 days
1012.5
TCGA-36-1576-01A
76 years, female, stage:Stage IIIC, alive, 915 days
1009.2
TCGA-29-2425-01A
60 years, female, white, stage:Stage IIIC, alive, 1977 days
1002.6
TCGA-13-1511-01A
52 years, female, asian, stage:Stage IV, dead, 1650 days
1002.2
TCGA-25-2409-01A
71 years, female, white, stage:Stage IV, dead, 821 days
1001.9
TCGA-30-1714-01A
68 years, female, white, stage:Stage IV, dead, 1158 days
1001.1
TCGA-23-1113-01A
48 years, female, white, stage:Stage IV, dead, 949 days
990.7
TCGA-31-1956-01A
60 years, female, white, stage:Stage IIIB, alive, 1342 days
985.2
TCGA-04-1536-01A
60 years, female, black or african american, stage:Stage IV, dead, 885 days
974.1
TCGA-36-1580-01A
82 years, female, stage:Stage IIIC, dead, 737 days
972.2
TCGA-61-1741-01A
76 years, female, white, stage:Stage IIIB, dead, 1024 days
970.4
TCGA-23-1028-01A
43 years, female, white, stage:Stage IIIC, alive, 1503 days
965.3
TCGA-61-2098-01A
62 years, female, white, stage:Stage IIIC, alive, 1993 days
959.9
TCGA-24-1924-01A
65 years, female, white, stage:Stage IIIC, dead, 919 days
959.0
TCGA-13-1495-01A
60 years, female, white, stage:Stage IIIC, dead, 2749 days
951.9
TCGA-04-1365-01A
87 years, female, white, stage:Stage IIIB, alive, 947 days
948.9
TCGA-29-1784-01A
55 years, female, white, stage:Stage IIIC, alive, 163 days
947.0
TCGA-29-1688-01A
39 years, female, white, stage:Stage IIIC, dead, 2400 days
946.7
TCGA-25-2398-01A
71 years, female, white, stage:Stage IIIC, dead, 1369 days
944.9
TCGA-24-2024-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
942.4
TCGA-29-1696-01A
43 years, female, white, stage:Stage IIIC, dead, 1032 days
941.5
TCGA-20-1683-01A
65 years, female, white, stage:Stage IIIC, alive, 772 days
940.8
TCGA-20-0991-01A
78 years, female, white, stage:Stage IIB, alive, 797 days
933.8
TCGA-24-2020-01A
67 years, female, white, stage:Stage IIIC, dead, 4624 days
924.1
TCGA-24-2267-01A
58 years, female, white, stage:Stage IIB, dead, 1446 days
921.0
TCGA-10-0928-01A
71 years, female, white, stage:Stage IIIC, dead, 563 days
916.4
TCGA-24-1560-01A
51 years, female, white, stage:Stage IIIC, dead, 1341 days
916.1
TCGA-13-1410-01A
57 years, female, white, stage:Stage IV, alive, 2464 days
899.7
TCGA-24-1558-01A
73 years, female, white, stage:Stage IIIC, dead, 594 days
888.9
TCGA-25-2400-01A
76 years, female, white, stage:Stage IIIC, dead, 1278 days
885.9
TCGA-25-1312-01A
69 years, female, white, stage:Stage IV, dead, 31 days
881.0
TCGA-24-0968-01A
59 years, female, white, stage:Stage IIIC, dead, 598 days
875.1
TCGA-13-1411-01A
81 years, female, white, stage:Stage IIIC, dead, 531 days
874.8
TCGA-09-0367-01A
67 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
866.2
TCGA-30-1891-01A
61 years, female, white, stage:Stage IIIC, dead, 914 days
865.0
TCGA-25-1628-01A
67 years, female, white, stage:Stage IIIC, dead, 627 days
860.2
TCGA-13-0795-01A
66 years, female, white, stage:Stage IIIC, dead, 619 days
856.6
TCGA-57-1994-01A
63 years, female, white, stage:'--, alive, 761 days
848.2
TCGA-25-1313-01A
62 years, female, white, stage:Stage IV, dead, 820 days
845.0
TCGA-24-1418-01A
68 years, female, white, stage:Stage IIIC, alive, 243 days
840.9
TCGA-61-2088-01A
51 years, female, white, stage:Stage IIIC, alive, 145 days
836.1
TCGA-29-1781-01A
69 years, female, white, stage:Stage IIIC, alive, 255 days
833.4
TCGA-24-1428-01A
50 years, female, white, stage:Stage IIIC, alive, 529 days
831.9
TCGA-25-1870-01A
59 years, female, white, stage:Stage IIIC, dead, 455 days
829.9
TCGA-30-1862-01A
65 years, female, white, stage:Stage IV, dead, 186 days
828.8
TCGA-04-1519-01A
48 years, female, stage:Stage IIIC, alive, 24 days
821.2
TCGA-24-2293-01A
47 years, female, white, stage:'--, dead, 506 days
818.7
TCGA-59-2351-01A
51 years, female, white, stage:Stage IIIC, alive, 3532 days
817.8
TCGA-23-1030-01A
64 years, female, white, stage:Stage IIIC, alive, 886 days
812.6
TCGA-13-0797-01A
49 years, female, white, stage:Stage IIIC, alive, 2121 days
810.0
TCGA-25-1321-01A
65 years, female, white, stage:Stage IIIC, dead, 1033 days
809.2
TCGA-13-1509-01A
64 years, female, white, stage:Stage IV, alive, 2438 days
807.7
TCGA-24-2254-01A
66 years, female, white, stage:Stage IIIC, dead, 1736 days
802.9
TCGA-61-2104-01A
53 years, female, white, stage:Stage IIC, alive, 2338 days
796.9
TCGA-61-2003-01A
53 years, female, white, stage:Stage IIIC, alive, 122 days
793.0
TCGA-04-1655-01A
49 years, female, white, stage:Stage IIIB, dead, 1380 days
790.2
TCGA-25-1630-01A
73 years, female, white, stage:Stage IIIC, dead, 1162 days
786.1
TCGA-13-0766-01A
42 years, female, white, stage:Stage IIIC, dead, 1725 days
782.8
TCGA-31-1959-01A
49 years, female, white, stage:Stage IV, alive, 67 days
779.4
TCGA-20-1682-01A
56 years, female, white, stage:Stage IIIC, alive, 837 days
771.3
TCGA-13-1499-01A
56 years, female, white, stage:Stage IIIC, alive, 3500 days
769.7
TCGA-24-1557-01A
49 years, female, white, stage:Stage IIIC, dead, 1213 days
769.2
TCGA-23-1109-01A
62 years, female, white, stage:Stage IIIC, dead, 1562 days
763.7
TCGA-24-1549-01A
58 years, female, white, stage:Stage IIIB, dead, 1721 days
757.7
TCGA-31-1953-01A
52 years, female, asian, stage:Stage IIIC, alive, 204 days
752.9
TCGA-36-1577-01A
43 years, female, asian, stage:Stage IIC, alive, 783 days
749.8
TCGA-23-2077-01A
45 years, female, white, stage:Stage IIIC, alive, 3525 days
744.9
TCGA-24-1426-01A
43 years, female, white, stage:Stage IIIC, alive, 163 days
741.4
TCGA-13-0924-01A
45 years, female, white, stage:Stage IV, alive, 2614 days
740.4
TCGA-61-1738-01A
60 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
737.7
TCGA-13-1506-01A
45 years, female, white, stage:Stage IIIC, dead, 1039 days
736.3
TCGA-04-1530-01A
68 years, female, white, stage:Stage IIIC, dead, 3622 days
735.7
TCGA-29-1785-01A
55 years, female, white, stage:Stage IIIC, dead, 1104 days
733.8
TCGA-57-1585-01A
57 years, female, white, stage:Stage IIIC, dead, 53 days
728.5
TCGA-29-1770-01A
54 years, female, white, stage:Stage IIIC, alive, 741 days
728.2
TCGA-57-1583-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 346 days
726.3
TCGA-09-1666-01A
57 years, female, white, stage:Stage IIIC, alive, 1752 days
726.3
TCGA-25-1315-01A
50 years, female, white, stage:Stage IIIC, dead, 1583 days
723.5
TCGA-13-1477-01A
49 years, female, white, stage:Stage IV, dead, 1662 days
714.9
TCGA-24-2026-01A
79 years, female, white, stage:Stage IIIC, dead, 1059 days
713.3
TCGA-29-1697-01A
62 years, female, white, stage:Stage IIIC, dead, 949 days
697.5
TCGA-09-1669-01A
54 years, female, white, stage:Stage IIIA, alive, 928 days
696.5
TCGA-24-1544-01A
71 years, female, black or african american, stage:Stage IIIC, dead, 820 days
686.0
TCGA-29-2427-01A
60 years, female, white, stage:Stage IIIC, alive, 1900 days
684.4
TCGA-13-0800-01A
52 years, female, white, stage:Stage IIIC, alive, 2661 days
681.7
TCGA-04-1514-01A
45 years, female, white, stage:Stage IIIA, dead, 1720 days
678.5
TCGA-04-1350-01A
46 years, female, white, stage:Stage IIIC, dead, 1946 days
676.9
TCGA-24-1930-01A
53 years, female, white, stage:Stage IIIC, dead, 2467 days
674.6
TCGA-13-0725-01A
44 years, female, white, stage:Stage IIIC, dead, 377 days
674.6
TCGA-13-1488-01A
59 years, female, white, stage:Stage IV, dead, 2154 days
667.7
TCGA-24-1104-01A
56 years, female, white, stage:Stage IV, dead, 1933 days
663.7
TCGA-13-1498-01A
73 years, female, white, stage:Stage IIIC, dead, 2012 days
661.2
TCGA-23-1123-01A
59 years, female, white, stage:Stage IIIC, dead, 1018 days
660.8
TCGA-24-1928-01A
77 years, female, white, stage:Stage IIIC, dead, 336 days
658.8
TCGA-23-1027-01A
48 years, female, white, stage:Stage IIIC, dead, 976 days
655.6
TCGA-23-1120-01A
60 years, female, white, stage:Stage IIIC, alive, 130 days
654.5
TCGA-29-1769-01A
40 years, female, white, stage:Stage IIIC, alive, 699 days
653.5
TCGA-61-2110-01A
56 years, female, white, stage:Stage IIIC, dead, 1354 days
649.5
TCGA-13-0765-01A
50 years, female, white, stage:Stage IIIC, dead, 1389 days
646.8
TCGA-13-1489-01A
70 years, female, white, stage:Stage IIIC, dead, 2553 days
642.8
TCGA-24-1423-01A
61 years, female, white, stage:Stage IIIC, alive, 190 days
641.7
TCGA-30-1718-01A
44 years, female, white, stage:Stage IIIC, dead, 1579 days
641.0
TCGA-57-1993-01A
56 years, female, white, stage:Stage IIIC, alive, 763 days
632.1
TCGA-23-1023-01A
65 years, female, white, stage:Stage IIIC, alive, 1233 days
626.0
TCGA-04-1332-01A
70 years, female, white, stage:Stage IIIC, dead, 1247 days
625.6
TCGA-10-0931-01A
44 years, female, white, stage:Stage IIIC, dead, 1000 days
622.4
TCGA-61-2101-01A
55 years, female, white, stage:Stage IIIC, dead, 1688 days
613.7
TCGA-29-1693-01A
72 years, female, white, stage:Stage IIIC, alive, 3096 days
607.9
TCGA-61-1911-01A
55 years, female, white, stage:Stage IIA, alive, 1293 days
606.0
TCGA-13-1405-01A
49 years, female, white, stage:Stage IV, dead, 868 days
605.3
TCGA-13-0897-01A
54 years, female, white, stage:Stage IIIC, dead, 2182 days
604.6
TCGA-13-0762-01A
65 years, female, white, stage:Stage IIIC, alive, 3400 days
594.7
TCGA-24-1431-01A
67 years, female, white, stage:Stage IIIC, dead, 583 days
593.1
TCGA-25-2396-01A
71 years, female, white, stage:Stage IIIC, dead, 92 days
590.1
TCGA-29-1710-01A
54 years, female, white, stage:Stage IIIC, dead, 951 days
589.7
TCGA-61-2009-01A
65 years, female, white, stage:Stage IIIC, alive, 1212 days
588.3
TCGA-24-2280-01A
74 years, female, white, stage:Stage IIIC, alive, 2143 days
582.1
TCGA-61-1721-01A
38 years, female, white, stage:Stage IV, alive, 338 days
578.8
TCGA-10-0933-01A
77 years, female, white, stage:Stage IIIC, dead, 446 days
576.0
TCGA-20-0987-01A
61 years, female, white, stage:Stage IIIC, dead, 701 days
573.8
TCGA-13-0906-01A
50 years, female, white, stage:Stage IIIC, alive, 3619 days
565.3
TCGA-30-1866-01A
61 years, female, white, stage:Stage IV, dead, 1114 days
564.9
TCGA-04-1648-01A
57 years, female, white, stage:Stage IIIC, dead, 871 days
562.6
TCGA-29-1763-01A
43 years, female, black or african american, stage:Stage IIC, alive, 2032 days
561.3
TCGA-13-0768-01A
73 years, female, white, stage:Stage IIIC, dead, 1784 days
558.5
TCGA-59-2352-01A
78 years, female, white, stage:Stage IIIC, dead, 286 days
557.6
TCGA-25-1634-01A
75 years, female, white, stage:Stage IIIC, dead, 1091 days
555.2
TCGA-09-2054-01A
58 years, female, black or african american, stage:Stage IIIC, dead, 637 days
554.2
TCGA-24-2288-01A
70 years, female, white, stage:Stage IIIC, dead, 25 days
550.3
TCGA-13-0911-01A
55 years, female, white, stage:Stage IV, dead, 1355 days
549.6
TCGA-23-1122-01A
53 years, female, white, stage:Stage IIIC, dead, 1189 days
546.8
TCGA-25-1626-01A
65 years, female, white, stage:Stage IIIC, dead, 518 days
546.7
TCGA-61-1914-01A
65 years, female, stage:Stage IIIC, alive, 1722 days
528.7
TCGA-04-1341-01A
85 years, female, white, stage:'--, alive, 33 days
520.6
TCGA-24-1424-01A
67 years, female, white, stage:Stage IIIC, alive, 183 days
520.1
TCGA-09-2045-01A
50 years, female, asian, stage:Stage IV, dead, 1069 days
517.7
TCGA-24-1843-01A
66 years, female, white, stage:Stage IIIC, alive, 106 days
517.7
TCGA-24-1850-01A
72 years, female, white, stage:Stage IIIC, alive, 168 days
515.2
TCGA-13-1510-01A
62 years, female, white, stage:Stage IIIC, dead, 1359 days
512.6
TCGA-29-1766-01A
74 years, female, white, stage:Stage IIIC, dead, 1199 days
503.6
TCGA-29-1761-01A
80 years, female, asian, stage:Stage IIIC, dead, 528 days
500.1
TCGA-29-1711-01A
45 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
499.7
TCGA-24-1845-01A
42 years, female, white, stage:Stage IIIC, alive, 116 days
492.2
TCGA-04-1331-01A
78 years, female, white, stage:Stage IIIC, dead, 1336 days
476.5
TCGA-04-1343-01A
72 years, female, white, stage:Stage IV, dead, 361 days
475.5
TCGA-31-1950-01A
76 years, female, white, stage:Stage IIIC, alive, 571 days
475.3
TCGA-13-1497-01A
47 years, female, white, stage:Stage IIIC, alive, 3871 days
471.3
TCGA-24-2036-01A
50 years, female, white, stage:Stage IIIA, dead, 1947 days
459.9
TCGA-23-1107-01A
59 years, female, white, stage:Stage IV, dead, 9 days
455.5
TCGA-13-0730-01A
71 years, female, white, stage:Stage IIIC, dead, 542 days
449.7
TCGA-13-0727-01A
71 years, female, white, stage:Stage IIIC, dead, 462 days
446.5
TCGA-13-1492-01A
66 years, female, white, stage:Stage IIIC, dead, 3819 days
437.7
TCGA-61-1733-01A
71 years, female, white, stage:Stage IIIC, alive, 967 days
429.7
TCGA-36-1581-01A
63 years, female, white, stage:Stage IIC, alive, 751 days
422.7
TCGA-24-0966-01A
78 years, female, black or african american, stage:Stage IIIC, alive, 232 days
421.6
TCGA-61-2102-01A
74 years, female, white, stage:Stage IIIC, dead, 197 days
417.4
TCGA-13-1407-01A
51 years, female, white, stage:Stage IIIC, alive, 2534 days
413.6
TCGA-13-0916-01A
49 years, female, white, stage:Stage IIIC, alive, 1785 days
411.8
TCGA-29-2428-01A
58 years, female, white, stage:Stage IIIC, alive, 1372 days
399.2
TCGA-23-1809-01A
63 years, female, white, stage:Stage IIC, alive, 16 days
391.5
TCGA-23-1110-01A
42 years, female, white, stage:Stage IIIC, alive, 1658 days
383.9
TCGA-59-2350-01A
44 years, female, stage:Stage IV, dead, 679 days
382.5
TCGA-24-1469-01A
71 years, female, white, stage:Stage IIIC, alive, 277 days
381.7
TCGA-61-1900-01A
51 years, female, black or african american, stage:Stage IIIB, alive, 176 days
375.3
TCGA-25-1877-01A
81 years, female, white, stage:Stage IIIC, dead, 730 days
371.3
TCGA-13-0888-01A
78 years, female, white, stage:Stage IIIC, dead, 2811 days
363.6
TCGA-29-1691-01A
51 years, female, white, stage:Stage IIIC, dead, 1470 days
361.1
TCGA-25-1319-01A
73 years, female, white, stage:Stage IIIC, dead, 1977 days
330.8
TCGA-13-0804-01A
73 years, female, white, stage:Stage IIIC, dead, 1073 days
329.6
TCGA-29-1774-01A
82 years, female, white, stage:Stage IIIC, alive, 527 days
319.0
TCGA-13-0891-01A
73 years, female, white, stage:Stage IV, dead, 3128 days
317.2
TCGA-61-2012-01A
81 years, female, white, stage:Stage IIC, alive, 932 days
315.9
TCGA-13-0887-01A
42 years, female, white, stage:Stage IIIC, dead, 2028 days
312.5
TCGA-13-1496-01A
65 years, female, white, stage:Stage IIIC, dead, 129 days
311.5
TCGA-09-2048-01A
63 years, female, white, stage:Stage IIIC, dead, 138 days
295.5
TCGA-13-0923-01A
74 years, female, white, stage:Stage IIIC, alive, 2547 days
280.9
TCGA-09-0366-01A
55 years, female, white, stage:Stage IIIC, dead, 1757 days
269.1
TCGA-29-1762-01A
59 years, female, white, stage:Stage IV, dead, 2634 days
263.6
TCGA-13-0920-01A
65 years, female, white, stage:Stage IIIC, dead, 1484 days
258.7
TCGA-13-1507-01A
77 years, female, white, stage:Stage IIIC, dead, 1993 days
253.5
TCGA-29-1777-01A
47 years, female, white, stage:Stage IIIC, alive, 374 days
230.0
TCGA-09-0369-01A
56 years, female, white, stage:Stage IIIC, dead, 1082 days
226.8
TCGA-04-1347-01A
81 years, female, white, stage:Stage IV, alive, 1919 days
203.9
TCGA-30-1860-01A
58 years, female, white, stage:Stage IIIC, dead, 1366 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
PABPC1 is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average pTPM
939.3
Number of samples
81
Samples
Sample
Description
pTPM
DO46551
58 years, female, NA, stage:III, dead, 1055 days
2957.1
DO46518
62 years, female, NA, stage:III, alive, 2960 days
2323.0
DO46611
52 years, female, NA, stage:III, dead, 734 days
2292.2
DO46331
72 years, female, NA, stage:III, dead, 612 days
2105.9
DO46380
51 years, female, NA, stage:III, dead, 1423 days
2036.7
DO46538
57 years, female, NA, stage:III, dead, 1527 days
1874.4
DO46342
67 years, female, NA, stage:III, dead, 1398 days
1866.8
DO46404
55 years, female, NA, stage:III, dead, 690 days
1579.5
DO46597
60 years, female, NA, stage:III, dead, 393 days
1419.6
DO46392
48 years, female, NA, stage:III, dead, 628 days
1391.9
DO46568
66 years, female, NA, stage:III, dead, 320 days
1389.0
DO46346
54 years, female, NA, stage:III, dead, 1187 days
1321.2
DO46372
39 years, female, NA, stage:III, dead, 1326 days
1312.5
DO46390
65 years, female, NA, stage:III, dead, 374 days
1269.4
DO46384
55 years, female, NA, stage:III, dead, 614 days
1264.4
DO46344
46 years, female, NA, stage:III, dead, 642 days
1240.6
DO46546
73 years, female, NA, stage:III, dead, 1889 days
1228.6
DO46333
58 years, female, NA, stage:III, dead, 359 days
1181.5
DO46586
55 years, female, NA, stage:III, dead, 1019 days
1150.8
DO46408
56 years, female, NA, stage:III, dead, 489 days
1118.6
DO46366
65 years, female, NA, stage:III, dead, 2054 days
1107.4
DO46493
62 years, female, NA, stage:IV, alive, 839 days
1058.0
DO46356
68 years, female, NA, stage:III, dead, 911 days
1038.8
DO46388
74 years, female, NA, stage:III, dead, 413 days
1016.0
DO46581
66 years, female, NA, stage:III, dead, 408 days
1015.3
DO46513
54 years, female, NA, stage:IV, dead, 1883 days
983.5
DO46400
70 years, female, NA, stage:III, dead, 719 days
964.8
DO46330
60 years, female, NA, stage:III, dead, 684 days
940.7
DO46340
62 years, female, NA, stage:III, dead, 616 days
913.1
DO46328
52 years, female, NA, stage:III, dead, 972 days
904.4
DO46576
75 years, female, NA, stage:III, alive, 133 days
903.6
DO46588
74 years, female, NA, stage:III, dead, 438 days
900.9
DO46338
59 years, female, NA, stage:III, dead, 596 days
897.6
DO46348
58 years, female, NA, stage:IV, dead, 287 days
890.7
DO46402
77 years, female, NA, stage:III, dead, 511 days
867.6
DO46325
54 years, female, NA, stage:III, dead, 477 days
865.5
DO46533
46 years, female, NA, stage:III, alive, 3667 days
865.0
DO46360
58 years, female, NA, stage:IV, dead, 1759 days
859.6
DO46463
49 years, female, NA, stage:III, dead, 2451 days
819.7
DO46602
74 years, female, NA, stage:III, dead, 205 days
819.0
DO46508
50 years, female, NA, stage:III, dead, 2101 days
799.4
DO46453
66 years, female, NA, stage:III, dead, 3294 days
799.2
DO46327
54 years, female, NA, stage:III, dead, 184 days
795.7
DO46326
51 years, female, NA, stage:III, dead, 701 days
768.0
DO46394
61 years, female, NA, stage:IV, dead, 1039 days
765.7
DO46438
55 years, female, NA, stage:IV, alive, 2227 days
761.4
DO46329
52 years, female, NA, stage:III, dead, 1699 days
743.4
DO46370
54 years, female, NA, stage:III, dead, 1727 days
741.1
DO46443
59 years, female, NA, stage:III, dead, 2464 days
735.3
DO46436
58 years, female, NA, stage:III, alive, 3193 days
733.9
DO46376
58 years, female, NA, stage:III, dead, 1430 days
721.3
DO46523
52 years, female, NA, stage:IV, alive, 1873 days
717.7
DO46412
64 years, female, NA, stage:III, dead, 597 days
711.7
DO46354
73 years, female, NA, stage:III, dead, 843 days
703.3
DO46386
49 years, female, NA, stage:III, dead, 1162 days
700.8
DO46528
56 years, female, NA, stage:III, alive, 6139 days
692.9
DO46566
78 years, female, NA, stage:III, dead, 673 days
690.4
DO46364
45 years, female, NA, stage:III, dead, 806 days
682.7
DO46432
56 years, female, NA, stage:III, alive, 2218 days
675.7
DO46334
77 years, female, NA, stage:III, dead, 496 days
673.1
DO46378
59 years, female, NA, stage:III, alive, 843 days
669.8
DO46560
45 years, female, NA, stage:IV, dead, 286 days
639.1
DO46591
58 years, female, NA, stage:III, dead, 195 days
638.8
DO46352
60 years, female, NA, stage:III, dead, 677 days
633.5
DO46448
45 years, female, NA, stage:III, dead, 654 days
617.3
DO46332
56 years, female, NA, stage:III, dead, 689 days
604.6
DO46571
61 years, female, NA, stage:III, dead, 243 days
578.2
DO46362
61 years, female, NA, stage:III, dead, 1639 days
559.1
DO46336
70 years, female, NA, stage:IV, dead, 664 days
536.5
DO46374
69 years, female, NA, stage:III, dead, 1409 days
534.8
DO46382
62 years, female, NA, stage:IV, dead, 311 days
499.4
DO46396
64 years, female, NA, stage:III, dead, 583 days
475.5
DO46398
66 years, female, NA, stage:III, alive, 437 days
460.4
DO46350
66 years, female, NA, stage:III, dead, 886 days
455.4
DO46468
67 years, female, NA, stage:III, alive, 2776 days
450.5
DO46358
60 years, female, NA, stage:III, dead, 423 days
446.5
DO46606
73 years, female, NA, stage:III, alive, 804 days
441.0
DO46368
57 years, female, NA, stage:III, dead, 2879 days
397.1
DO46428
59 years, female, NA, stage:IV, alive, 2644 days
328.0
DO46561
52 years, female, NA, stage:III, dead, 195 days
314.7
DO46458
67 years, female, NA, stage:IV, alive, 3787 days
235.8
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
1.2
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
1.2
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
1.1
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
1.1
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
1.1
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
1.0
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
1.0
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
1.0
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
0.9
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
0.9
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
0.9
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
0.9
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
0.9
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
0.9
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
0.9
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
0.8
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
0.8
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
0.8
e9d416e7-f661-400a-896e-388545_D2
Tumor
0.8
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
0.7
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
0.7
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
0.7
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
0.7
2f901c90-617e-46da-9fac-d68369_D2
Tumor
0.7
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
0.7
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
0.7
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
0.7
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
0.7
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
0.6
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
0.6
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
0.6
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
0.6
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
0.6
15524912-685a-47ce-a824-567848_D2
Tumor
0.6
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
0.6
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
0.6
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
0.6
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
0.6
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
0.6
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
0.5
1a10c200-3895-4648-b951-94f99f_D2
Tumor
0.5
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
0.5
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
0.5
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
0.5
1772e913-f62e-446a-8cf3-720348_D2
Tumor
0.5
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
0.5
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
0.5
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
0.5
10c2d629-0287-4511-ac25-f29031_D2
Tumor
0.5
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
0.5
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
0.5
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
0.5
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
0.4
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
0.4
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
0.4
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
0.4
285fed94-1495-448e-879b-b55de9_D2
Tumor
0.4
161317f3-1a39-438e-af45-cd2502_D2
Tumor
0.3
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
0.3
a3a26070-fb84-406a-8280-d555e6_D2
Normal
0.3
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
0.3
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
0.3
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
0.3
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
0.3
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
0.3
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
0.3
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
0.2
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
0.2
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
0.2
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
0.2
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
0.2
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
0.2
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
0.2
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
0.2
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
0.1
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
0.1
340a3769-3031-41ae-bb08-a2f696_D2
Normal
0.1
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
0.1
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
0.1
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
0.1
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
0.1
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
0.1
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
0.1
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
0.1
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
0.1
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
0.1
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
0.0
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
0.0
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
0.0
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
0.0
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
0.0
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
0.0
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
0.0
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-0.1
21efd60f-6a31-4b98-9477-16a905_D2
Normal
-0.1
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
-0.1
a65d8e76-640f-4341-a561-afbb57_D2
Normal
-0.1
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
-0.2
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
-0.2
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
-0.2
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
-0.2
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
-0.3
1db5574d-aca7-403c-8100-6e705f_D2
Normal
-0.3
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
-0.4
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
-0.4
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
-0.5
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
-0.5
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
-0.7
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.
The Human Protein Atlas project is funded
